EUC Annex 22 on AI & CIMCON Software

 


This annex outlines guidance for using AI/ML models in GMP manufacturing of medicines and active substances. It applies to static, deterministic models used in critical applications, excluding dynamic, probabilistic, and generative AI like LLMs.


Comments

Popular posts from this blog

Key Requirements of Annex 22 for AI Models in Regulated Environments

Legacy Lab Applications – CIMCON Software

Validation as a Service (VaaS)